Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
about
Ubiquitin-proteasome system involvement in Huntington's diseaseAmyloid-mediated sequestration of essential proteins contributes to mutant huntingtin toxicity in yeastHuntingtin interacting proteins are genetic modifiers of neurodegenerationOligonucleotide therapeutic approaches for Huntington diseasep62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for bothThe Guanine nucleotide exchange factor kalirin-7 is a novel synphilin-1 interacting protein and modifies synphilin-1 aggregate transport and formationThe selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein AlfySCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibitionRhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicityMutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesPumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levelsHDAC6 and microtubules are required for autophagic degradation of aggregated huntingtinHuntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicityClioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.Clarifying lysosomal storage diseasesImproved activities of CREB binding protein, heterogeneous nuclear ribonucleoproteins and proteasome following downregulation of noncoding hsromega transcripts help suppress poly(Q) pathogenesis in fly modelsThe ubiquitin proteasome system in neuropathologyPalmitoylation of huntingtin by HIP14 is essential for its trafficking and functionAutophagy and the ubiquitin-proteasome system: collaborators in neuroprotectionMisfolded proteins partition between two distinct quality control compartmentsAmyloids: friend or foe?Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer diseaseTau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's DiseasePrecision medicine in spinocerebellar ataxias: treatment based on common mechanisms of diseaseAdaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbationsMetazoan Hsp70-based protein disaggregases: emergence and mechanismsTreatment of Huntington's disease.Disaggregases, molecular chaperones that resolubilize protein aggregatesRegulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genesProtein Folding and Mechanisms of ProteostasisPhysicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs)RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disordersCell biology of spinocerebellar ataxiaSorting out the trash: the spatial nature of eukaryotic protein quality controlTargeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseasesPotential mechanisms of progranulin-deficient FTLDLongitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative diseaseAutophagy and disease: always two sides to a problemModeling Huntington's disease with induced pluripotent stem cells
P2860
Q21129327-1CF0A98C-2E2C-4C0B-9D17-24B41F21D69FQ21134910-C8D37DDC-9801-4EAF-964D-1AD348AB8C0AQ21145230-B449AE7F-50A0-4092-8BB5-925BD09C3341Q22306293-2269A76C-D104-4E07-ACE6-1D20C26CB5CEQ24301629-94D24EC8-6A53-419C-A0B0-326F89D81556Q24307589-538258A9-6E26-4281-AA53-E75822CD6C52Q24307759-D0631306-88E4-4B8E-8BF2-9A67F6031A40Q24314585-823E6891-5405-43A0-817A-CEDBAC6DC83AQ24317318-6CD288BF-9242-4E5B-BB16-579FFBE234D6Q24318474-0423B432-A776-49E6-8259-5CDCAAE6EFD6Q24322711-D4175597-6A14-481A-A3B4-F9562734779FQ24337155-0DA7D31C-9BB7-4897-A7AA-0B1412524F35Q24337727-84ED7344-867C-4D8C-B224-9514BCFF9A30Q24535603-F2C70E81-9035-4000-9737-0C69C98D4913Q24620532-E7FB4AA6-08A7-412C-A60C-5E856E573AF4Q24626685-D8923E8C-86C6-481D-A099-1E418D28CF6AQ24644208-47A79BCB-4167-4B31-8CAF-D62D5EEB4D91Q24646918-83AB7930-B376-43D6-999A-4E6DE175C9E5Q24650675-606EE1F5-CD64-4A63-9877-300988D32358Q24651093-AD56E46B-01F1-4D3C-B786-6BE799408AAAQ24653554-AF1471DE-CC49-47C5-BBCB-174D2E3AFEDAQ24655547-4C62B243-58DA-4F90-BEBE-4E42169116DBQ24657243-974F56ED-49F5-4AB9-B14E-8C7E62390FF3Q26739412-65D3F9DC-E303-49F4-806D-33B614B986B3Q26764958-BC787663-3760-4C54-9724-D7EB40B7008AQ26765956-84F58102-8D51-4626-B72D-525B8338B5ADQ26779046-E36A45F6-A5A6-4514-B540-0F37DA16F989Q26782004-DBE898AB-EF8A-450D-9C48-674B1C693EFBQ26796603-16FDF07E-90D6-4126-9334-17567C78E8A6Q26799208-B473CE84-3ACC-4B04-B369-CBF5A8911873Q26801512-0FF3CE71-D298-4779-B3B5-25146A43443FQ26823798-91F47750-69DE-42B8-AF26-4D605FA9B9E7Q26823908-DCF6AE4B-028A-4242-8951-01DB62083C71Q26829511-75B3FE97-428C-4BB1-A4D4-95B29F82610AQ26849685-26E6C5F5-452B-455C-A65C-39443720140BQ26859909-C214FF94-EE56-4D43-B1ED-E9154406A9A1Q26863702-82DADF7A-AFCC-402E-981E-5ED4B27B6207Q26865220-4C7B7795-AFDD-49BA-AC85-F4C13DFC7F11Q26995401-A1D71E13-A005-4A91-8EB3-D3CC6A7C4369Q27004209-C6A37853-70C8-41B9-B9C5-F97C8157F6AE
P2860
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inclusion body formation reduc ...... and the risk of neuronal death
@ast
Inclusion body formation reduc ...... and the risk of neuronal death
@en
Inclusion body formation reduc ...... and the risk of neuronal death
@nl
type
label
Inclusion body formation reduc ...... and the risk of neuronal death
@ast
Inclusion body formation reduc ...... and the risk of neuronal death
@en
Inclusion body formation reduc ...... and the risk of neuronal death
@nl
prefLabel
Inclusion body formation reduc ...... and the risk of neuronal death
@ast
Inclusion body formation reduc ...... and the risk of neuronal death
@en
Inclusion body formation reduc ...... and the risk of neuronal death
@nl
P2093
P2860
P3181
P356
P1433
P1476
Inclusion body formation reduc ...... and the risk of neuronal death
@en
P2093
Erik S Schweitzer
Mark R Segal
Montserrat Arrasate
Siddhartha Mitra
Steven Finkbeiner
P2860
P2888
P304
P3181
P356
10.1038/NATURE02998
P407
P577
2004-10-14T00:00:00Z
P5875
P6179
1016382609